Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group
William Shomali(Stanford Medicine), Jason Gotlib(Stanford University), Andreas Reiter(Heidelberg University), Jay Patel(Memorial Sloan Kettering Cancer Center), Alessandro M. Vannucchi(University of Florence), Philomena Colucci(Incyte (United States)), Jean‐Jacques Kiladjian(Assistance Publique – Hôpitaux de Paris), Cheryl Langford(Stanford University), Tracy I. George(University of Utah)
Cited by 14
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k